Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide
Clinical trial NCT03700099 · UNKNOWN
Trial details
- NCT number
- NCT03700099
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-03
- Primary completion
- 2024-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.